What makes your product/innovation/process unique?
What does the future hold?
|Most important/significant development?||Although Mabs are still dominating, an increasing percentage of products consists of other molecule types, including bi- and multispecific antibodies.
Also, new modalities (incl. ADCs) are directed to smaller patient populations and/or more potent, which reduces the annual demands (kg/year) substantially.
|Upcoming trends?||Flexible SU plants with Process intensification seem to increasingly offer multi product capability and flexible scheduling and facility output.|
|Most important unsolved challenge?||Proper on- or at-line measurement and overarching feedback and/or feed forward control is becoming a must have.|
Single Use Event 2020Registration website for Single Use Event 2020
Single Use Event 2020Single Use Event 20200.00EUROnlineOnly2019-01-01T00:00:00Z
CORPUSCORPUSWillem Einthovenstraat 1 2342BH Oegstgeest Netherlands